ECGTC, programme & last call for abstracts

Mr. M. Kuiper mkuiper at hgmp.mrc.ac.uk
Sat Jul 8 00:24:57 EST 1995


     2nd EUROPEAN CONFERENCE ON GENE THERAPY OF CANCER
       King's College London, 7 and 8 September 1995


REGISTRATION
Contact the Conference Secretariat, European Conference on Gene
Therapy of Cancer, Department of Molecular Medicine, King's College
School of Medicine and Dentistry, Rayne Institute, 123 Coldharbour
Lane, London SE5 9NU, UK.
Tel: 0171 346 3126 Fax: 0171 733 3877.
E-mail: mkuiper at hgmp.mrc.ac.uk (please include full postal address).


DEADLINE FOR ABSTRACTS
31 July 1995


SCIENTIFIC ADVISORY COMMITTEE
Peter Beverley, London		Nick Lemoine, London
Claudio Bordignon, Milan	David Linch, London
Odile Cohen-Haguenauer, Paris	Roland Mertelsmann, Freiburg
Mary Collins, London		Ghulam Mufti, London
Gus Dagleish, London		Karol Sikora, London
Mike Dexter, Manchester		Robert Sobol, San Diego
Farzin Farzaneh, London		Joyce Taylor-Papadimitriou, London
Gordon Freeman, Boston		Dinko Valerio, Rijswijk
Scott Freeman, New Orleans	Robin Weiss, London


PROGRAMME

7   S E P T E M B E R   1 9 9 5
SESSION 1 - STRATEGIES AND DELIVERY SYSTEMS

09.00	Introduction and Welcome

09.15	Chair:  Robin Weiss
	
09.30	Francois-Loic Cosset - Retroviral vectors for receptor specific
	ligand mediated targeting
	
10.00	Walter Gunzburg - Breast specific promoters
	
10.30	K K Wong - Adeno-associated virus gene delivery to 			
	haematopoietic stem cells
	
11.00	Coffee Break

11.30	Yoshikazu Sugimoto - MDR1 and IRES vectors as a drug-selectable
	gene delivery system
	
12.00	Natasha Caplen - Liposome mediated gene transfer
	
12.30	Lunch Break


SESSION 2 - TUMOUR IMMUNOLOGY

13.30	Chair:  Peter Beverley
	
13:45	Vincent Brichard - Antigens recognised by anti-tumour CTL: 		
	tumour specificity and perspectives for immunotherapy of cancer
	
14:15	Hans Stauss - T cell immunity to oncogenic proteins
	
14:45	Dorothy Crawford - EBV antigens
	
15:15	Tea break

15:45	Per Peterson - In vitro activation of tumour-specific cytotoxic
	T-lymphocytes

16:15	Ronald Schwartz - The molecular basis of costimulation and 		
	anergy in murine T cell clones

16.45	Short presentation selected from submitted abstract

17.00	Poster Viewing/Trade Exhibition/Cocktail Reception
-19.30


8   S E P T E M B E R   1 9 9 5
SESSION 3 - IMMUNE GENE THERAPY

09.00	Chair:  Joyce Taylor-Papadimitriou

09:15	Laurence Zitvogel - Cancer vaccines engineered with IL-4/
	IL-12+B7-1: towards the adaptive immunotherapy using 			
	genetically modified dendritic cells

09:45	Mary Collins - Designing melanoma vaccines

10:15	James Zwiebel - IL2 modified endothelial cells for tumour 		
	targeting

10:45	Coffee break

11:15	Antonio Lanzavecchia - Alloantigen stimulation of tumour 		
	rejection

11:45	Freda Stevenson - Idiotypic vaccination against B-cell lymphoma

12:15	Short presentation: Farzin Farzaneh - B7.1/IL2 autologous 		
	vaccination

12:30	Lunch


SESSION 4 - NON-IMMUNE GENE THERAPY

13.30	Chair:  Claudio Bordignon

13.45	Mike Dexter - gene delivery to haematological stem cells

14.15	Nick Lemoine - Genetically directed enzyme prodrug therapy 		
	using tumour- and tissue-selective promoters

14.45	Giovanni Martinelli - Therapeutic role of antisense 			
	oligonucleotides in haematological malignancies

15.15	Tea break

15.45	Scott Freeman - The mechanism of tumour killing using suicide 	
	gene therapy

16.15	Short presentation

16.30	Robert Sobol - Summary of Gene Therapy of Cancer

17.00	Close



More information about the Bionews mailing list